GlycoMimetics
GLYC
$0.88
Share price
3.65%
Change (1 day)
-55.56%
Change (1 year)
Categories
Earnings for GlycoMimetics (GLYC)
Earnings in 2022 (TTM): -$62.68 M
According to GlycoMimetics 's latest financial reports the company's current earnings (TTM) are -$62.68 M. In 2021 the company made an earning of -$63.43 M a decrease over its 2020 earnings that were of -$51.03 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for GlycoMimetics from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$62.68 M | -1.19% |
| 2021 | -$63.43 M | 24.3% |
| 2020 | -$51.03 M | -11.86% |
| 2019 | -$57.9 M | 27.43% |
| 2018 | -$45.43 M | 36.5% |
| 2017 | -$33.29 M | 4.63% |
| 2016 | -$31.81 M | 149.11% |
| 2015 | -$12.77 M | 14.81% |
| 2014 | -$11.13 M | 4.87% |
| 2013 | -$10.61 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $20.51 B | -32,832.19% | 🇺🇸 USA |
 Pfizer PFE | $33.77 B | -53,984.07% | 🇺🇸 USA |
 Sanofi SNY | $9.45 B | -15,187.41% | 🇫🇷 France |
 Palatin Technologies PTN | -$37.34 M | -40.42% | 🇺🇸 USA |
 bluebird bio
BLUE | -$0.34 B | 438.40% | 🇺🇸 USA |